- What it is: Damage to the peripheral nerves, mostly in the hands and feet, caused by certain chemotherapy drugs.
- Common symptoms: Numbness, tingling, burning or shooting pain, cold sensitivity, and trouble with balance or fine hand tasks.
- Conventional care: Your oncologist may adjust or stop the chemotherapy; duloxetine is the only medicine with guideline support for painful neuropathy, with limited benefit, and exercise is often advised.
- How integrative care fits: Acupuncture, Ayurvedic therapies and individually prescribed herbs are used for symptom relief alongside, never in place of, your cancer care.
- Evidence at a glance: Limited for acupuncture, with mixed results against sham; very limited for Ayurveda (case reports) and for herbal medicine.
What is Chemotherapy-Induced Neuropathy?
Chemotherapy-induced peripheral neuropathy (CIPN) is damage to the nerves outside the brain and spinal cord caused by certain cancer drugs. It is a common side effect that can limit how much chemotherapy a person can receive.[1] For a condition like this, we ask that you are under a physician's care for it and that your treating team knows you are receiving complementary care.
Common symptoms
CIPN is usually sensory: numbness, tingling, burning or shooting pain, often starting in the toes and fingers.[1] Some people also have trouble with balance, buttoning clothes or feeling temperature, and for some survivors it lasts long after treatment ends.[1]
- Numbness or "pins and needles" in the hands and feet
- Burning, shooting or electric pain
- Unsteady walking or dropping things
- Sensitivity to cold[1]
Causes and risk factors
Several types of chemotherapy can damage peripheral nerves, including taxane and platinum drugs, and about 30 to 40 percent of people treated with neurotoxic chemotherapy develop CIPN. Severity varies widely from person to person.[1]
How it is diagnosed and treated conventionally
Your oncology team diagnoses CIPN from your symptoms and a neurological examination, and checks that the numbness is not due to another cause. If neuropathy becomes intolerable or limits function, the guideline advises clinicians to consider delaying, reducing, substituting or stopping chemotherapy.[2]
No agent is recommended to prevent CIPN. For established painful CIPN, duloxetine is the only drug with enough evidence to support its use, and its benefit is limited.[2] A later meta-analysis of 7 trials found duloxetine statistically similar to placebo and called for better trials.[3]
Why Chemotherapy-Induced Neuropathy calls for a whole-person approach
CIPN is a nerve injury, but it affects walking, sleep, work and mood, so supportive care often addresses more than the nerves. Because drug treatment offers limited benefit, many people look to non-drug approaches, and clinical guidelines have reviewed exercise and integrative options.[2, 4]
Complementary care here is aimed at symptoms and daily function, and it is added to your oncology care.
Drug-related nerve injury
Chemotherapy drugs injure sensory nerves in different ways depending on the agent, and there is no proven way to prevent this damage.[1, 2]
Pain and sensory symptoms
The symptoms are mostly sensory, with pain, numbness and tingling, and these can persist after chemotherapy ends.[1]
Strength, balance and activity
Exercise may help. A meta-analysis of 16 trials found that exercise improved neuropathic pain, balance, muscle strength and quality of life in people with CIPN, though it did not clearly improve neuropathy symptoms.[5]
Quality of life and well-being
Neuropathy can lower quality of life, and some acupuncture trials measure it. A pooled analysis of 5 sham-controlled trials found acupuncture improved quality of life more than placebo acupuncture.[6]
Acupuncture for Chemotherapy-Induced Neuropathy
What the research shows
The research suggests acupuncture may ease CIPN symptoms, but the results are mixed and many studies are small. A network meta-analysis of 33 trials (2,027 participants) found acupuncture-related treatments better than usual care, medication or supplements for symptoms, pain and quality of life.[7] A review of 9 trials, with a pooled analysis of 4 of them, found acupuncture may be better than vitamin B for sensory neuropathy, and called for higher-quality studies.[8]
The picture is less clear against sham treatment. A meta-analysis of 5 sham-controlled trials found no significant difference in neurotoxicity scores, but found that acupuncture reduced pain severity and pain interference and improved quality of life more than sham.[6] An overview of 51 reviews of acupuncture in cancer rated most as low in quality and called the evidence on neuropathy limited and inconsistent.[9]
Individual trials add detail. A pilot trial of 60 patients receiving oxaliplatin found that electroacupuncture eased neuropathy severity more than sham acupuncture during chemotherapy, but vibration and light-touch tests did not differ.[10] In another trial in cancer survivors, real and sham acupuncture both improved some sensory measures compared with usual care, with no difference between them.[11] In a German crossover trial of 60 patients, acupuncture compared with a waiting period improved nerve conduction measures and symptoms, though the control group received no treatment.[12]
How acupuncture may work
How acupuncture might help CIPN is not established. The German trial suggested it might support nerve regeneration, since nerve conduction measures improved, but that is a hypothesis from one study.[12] In another trial real and sham needling gave similar results, so effects of the needling itself were not shown.[11]
What treatment involves
Treatment uses fine, sterile, single-use needles, often with the needles placed on the hands, feet and legs, usually left in place for about 20 to 40 minutes. A course is several visits with reassessment. Trials gave weekly to twice-weekly sessions over several weeks, for example 10 weeks of treatment in the German trial and weekly electroacupuncture over 12 weeks in the oxaliplatin trial.[10, 12]
Serious problems from acupuncture are rare. In prospective studies, about 9 in 100 patients had a minor reaction such as bleeding, pain or redness at a needle site, and serious events occurred in about 1 in 10,000 patients.[13] People having chemotherapy should tell the practitioner first about low blood counts or low platelets, blood thinners, a recent fever, an implanted port, lymphedema, pregnancy, or a pacemaker (relevant to electroacupuncture). Your oncology team should know you are receiving acupuncture.
Ayurvedic medicine for Chemotherapy-Induced Neuropathy
The Ayurvedic view
In Ayurveda, numbness, tingling and pain in the limbs are traditionally linked to disturbed Vata, the principle said to govern movement and nerve function. This is a traditional framework, not a biomedical diagnosis.
Therapies that may be used
Ayurvedic care is described as personalized, with customized diets, lifestyle changes, medicines and cleansing therapies.[14] For someone in cancer treatment it is kept gentle:
- Diet and daily routine intended to calm Vata, such as warm, regular meals and steady sleep hours
- Warm oil massage of the hands and feet, applied gently
- Herbs prescribed by a qualified practitioner, after review of your medicines
- Panchakarma only where traditionally appropriate and medically sensible
Panchakarma is not appropriate during pregnancy, acute illness or frailty, and strong cleansing procedures are generally not suitable during active chemotherapy. Any such procedure would only be considered with your oncology team's knowledge and when it is medically sensible.
What the research shows
The research on Ayurveda for CIPN is very limited. A PubMed search found no clinical trials, only a case report of one patient with taxane-related CIPN who improved after an individualized Ayurvedic program of diet, lifestyle, medicines and detoxification therapies.[14] A single case cannot show that the treatment caused the improvement.
Herbal medicine for Chemotherapy-Induced Neuropathy
Herbs and formulas that have been studied
Studies have looked at traditional Chinese herbal formulas given with chemotherapy and at the Japanese herbal formula Goshajinkigan, mostly to prevent CIPN or reduce its severity.[15, 16] No specific Ayurvedic herb has been tested in a clinical trial for CIPN that we found.
What the research shows
The evidence is limited. A meta-analysis of 63 trials in colorectal cancer found that integrative herbal medicine appeared to reduce severe CIPN with some grading scales but not others. The authors noted the lack of blinding, risk of bias and short follow-up.[15]
For Goshajinkigan, two meta-analyses of five trials each reached similar conclusions. One found it unlikely to prevent CIPN and advised against standard use given low-quality evidence, and the other found it did not reduce the risk of CIPN with the main grading scale.[16, 17] The Society for Integrative Oncology breast cancer guideline found no strong evidence that ingested supplements help manage treatment side effects.[4]
Safety and herb-drug interactions
Herbs are active substances and can interact with medicines, which matters during cancer treatment. Reviews describe interactions with many prescription drugs, including blood thinners, and case reports describe bleeding when warfarin was combined with herbs including dang gui (Angelica sinensis), dan shen (Salvia miltiorrhiza), ginger, ginseng and Boswellia.[18, 19] The guideline also cautions against acetyl-L-carnitine for preventing CIPN because of possible harm.[4]
Herbs should not be started without your oncologist's knowledge. In one study, about one fifth of Ayurvedic products bought online contained detectable lead, mercury or arsenic.[20] Herbs should come from tested sources and be prescribed individually. Tell us if you are pregnant or breastfeeding, have liver or kidney disease, or have surgery planned.
Translating traditional medicine into modern biological language
The links drawn here are interpretation, not equivalence. Chinese medicine often describes numbness and pain in the limbs as qi and blood failing to nourish or flow through the channels, sometimes with cold. Researchers studying CIPN look at things that loosely parallel this picture: damage to sensory nerve fibers, altered nerve conduction and the way pain is processed.[1, 12]
Ayurveda's disturbed Vata describes numbness and pain with unsteady movement. No study has shown that a dosha or a pattern corresponds to a specific biological process.
How this care fits with your medical care
Integrative care for CIPN is complementary and supports symptoms; it does not treat the cancer. Keep your oncologist, and do not stop or change chemotherapy or other prescribed medicines without your prescriber. Report new or worsening neuropathy to your oncology team promptly, since they may adjust treatment.[2]
Exercise has the clearest supporting evidence for function, so ask your team about it as well.[5] Please bring your cancer diagnosis, your chemotherapy schedule and list of drugs, recent blood counts, a full list of medicines and supplements, and notes from your oncologist or physical therapist.
When to seek urgent medical care
Call your oncology team promptly for new or worsening neuropathy, and seek emergency care for symptoms that could be serious.[2]
- Fever or chills during chemotherapy, which can mean a dangerous infection
- New weakness in the arms or legs, or falls and severe trouble walking
- Sudden loss of bladder or bowel control, or numbness in the groin
- Burns, cuts or sores on numb hands or feet that you did not feel, or that are not healing
- Sudden severe pain, or numbness spreading quickly up the limbs
- New confusion, trouble speaking, or weakness on one side of the body
If any of these occur, call 911 or go to the nearest emergency department.
Frequently asked questions
What is chemotherapy-induced neuropathy?
Chemotherapy-induced peripheral neuropathy is damage to nerves in the hands and feet caused by certain cancer drugs. It causes numbness, tingling, burning pain and sometimes balance problems. About 30 to 40 percent of people given neurotoxic chemotherapy develop it, and it can last after treatment ends. Your oncology team manages it and may adjust treatment.
Can acupuncture help with chemotherapy-induced neuropathy?
It may help, but the evidence is mixed. Several meta-analyses found better symptoms, pain and quality of life with acupuncture, but many trials were small or unblinded, and some sham-controlled comparisons showed little difference in neuropathy scores. Acupuncture is used for symptom relief alongside cancer care, with your oncology team’s knowledge.
Does Ayurvedic or herbal medicine work for chemotherapy-induced neuropathy?
There is very little reliable evidence. Ayurveda has only case reports, and herbal formulas such as Goshajinkigan have not been shown to prevent CIPN in reviews of small trials. Herbs can interact with cancer drugs and other medicines, so nothing should be started without your oncologist knowing.
Can I stop or change my chemotherapy or other medicines if I have acupuncture?
No. Acupuncture, Ayurveda and herbal medicine are complementary care and never replace cancer treatment. Do not stop or change chemotherapy or any prescribed medicine without your oncology team. If neuropathy is getting worse, tell your oncologist promptly because they may be able to adjust your treatment.
How soon might I notice a change with acupuncture?
It differs from person to person and no result can be promised. In trials, courses ran from several weeks to 12 weeks of treatment. A course is several visits with reassessment to see whether treatment is helping.
Does insurance cover acupuncture for neuropathy?
It may. Netra Integrative Health Clinic accepts most major insurance plans that include out-of-network acupuncture benefits, for example Aetna, Blue Cross Blue Shield, Cigna and UnitedHealthcare, and offers a free benefits check. HSA and FSA cards and CareCredit are also accepted. Call (908) 402-7301 to ask about your plan.
References
- Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81(6):772-781. PMID 28486769. Annals of Neurology review of CIPN: it affects about 30 to 40 percent of patients on neurotoxic chemotherapy, is sensory-predominant and painful, and can cause long-term morbidity.
- Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020;38(28):3325-3348. PMID 32663120. ASCO guideline update: no agent recommended for prevention, duloxetine the only supported drug for painful CIPN with limited benefit, and chemotherapy adjustment for intolerable neuropathy.
- Chow R, Novosel M, So OW, et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13(1):27-34. PMID 36194493. Meta-analysis of 7 trials (645 patients) finding duloxetine statistically similar to placebo for treating or preventing CIPN, with limited evidence.
- Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194-232. PMID 28436999. Society for Integrative Oncology breast cancer guideline covering integrative therapies for treatment side effects, including CIPN, and cautioning against acetyl-L-carnitine and supplements.
- Guo S, Han W, Wang P, et al. Effects of exercise on chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis. J Cancer Surviv. 2023;17(2):318-331. PMID 35149899. Meta-analysis of 16 trials finding exercise improved neuropathic pain, balance, strength and quality of life in CIPN, but not CIPN symptoms overall.
- Xu Z, Wang X, Wu Y, et al. The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Front Neurol. 2022;13:963358. PMID 36262831. Meta-analysis of 5 sham-controlled trials finding no significant neurotoxicity score difference but less pain and better quality of life with acupuncture.
- Yeh ML, Liao RW, Yeh PH, et al. Acupuncture-related interventions improve chemotherapy-induced peripheral neuropathy: A systematic review and network meta-analysis. BMC Complement Med Ther. 2024;24(1):310. PMID 39160496. Network meta-analysis of 33 trials (2,027 participants) finding acupuncture-related interventions better than usual care or medication for CIPN symptoms, pain and quality of life.
- Pei LX, Yi Y, Guo J, et al. The effectiveness and safety of acupuncture/electroacupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Acupunct Med. 2023;41(2):73-85. PMID 35695033. Meta-analysis of 9 trials (582 patients) suggesting acupuncture may beat vitamin B for sensory neuropathy, with unclear bias and a call for better trials.
- Zhang XW, Hou WB, Pu FL, et al. Acupuncture for cancer-related conditions: An overview of systematic reviews. Phytomedicine. 2022;106:154430. PMID 36099656. Overview of 51 systematic reviews of acupuncture in cancer, mostly low quality, finding limited and inconsistent evidence for CIPN.
- Chan K, Lui L, Lam Y, et al. Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial. Acupunct Med. 2023;41(5):268-283. PMID 36325677. Pilot sham-controlled trial of 60 colorectal cancer patients finding electroacupuncture eased oxaliplatin neuropathy severity, without differences in vibration or touch tests.
- Zhi WI, Baser RE, Talukder D, et al. Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing. Breast Cancer Res Treat. 2023;197(3):535-545. PMID 36527520. Randomized trial comparing real acupuncture, sham and usual care in cancer survivors; both acupuncture arms improved some sensory thresholds versus usual care, with no real-versus-sham difference.
- Friedemann T, Kark E, Cao N, et al. Acupuncture improves chemotherapy-induced neuropathy explored by neurophysiological and clinical outcomes - The randomized, controlled, cross-over ACUCIN trial. Phytomedicine. 2022;104:154294. PMID 35785559. Randomized crossover trial of 60 patients finding acupuncture improved sural nerve measures and symptoms compared with a waiting period.
- Bäumler P, Zhang W, Stübinger T, et al. Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. BMJ Open. 2021;11(9):e045961. PMID 34489268. Systematic review of 21 prospective studies finding minor acupuncture reactions in about 9 percent of patients and serious events in about 1 per 10,000.
- Buch Z, Hegde S, Lakshmi A, et al. Classical ayurveda management of TCH (taxane, carboplatin, and herceptin) based chemotherapy induced peripheral neuropathy- A case report. J Ayurveda Integr Med. 2024;15(5):101044. PMID 39244869. Case report of one patient with taxane-related CIPN who improved after an individualized Ayurvedic program of diet, lifestyle, medicines and detoxification therapies.
- Liu Y, May BH, Zhang AL, et al. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis. Integr Cancer Ther. 2019;18:1534735418817833. PMID 30526124. Meta-analysis of 63 trials (4,286 patients) finding integrative herbal medicine appeared to reduce CIPN in colorectal cancer, limited by lack of blinding and bias.
- Kuriyama A, Endo K. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Support Care Cancer. 2018;26(4):1051-1059. PMID 29280005. Meta-analysis of 5 trials (397 patients) concluding Goshajinkigan is unlikely to prevent CIPN, with low-quality evidence.
- Hoshino N, Ganeko R, Hida K, et al. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Int J Clin Oncol. 2018;23(3):434-442. PMID 29270698. Meta-analysis of 5 trials of Goshajinkigan finding no reduction in CIPN risk with the common toxicity criteria, and calling for better trials.
- Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239-82. PMID 15916450. Literature review of herb-drug interactions including enhanced bleeding with warfarin and other serious clinical consequences.
- Milić N, Milosević N, Golocorbin Kon S, et al. Warfarin interactions with medicinal herbs. Nat Prod Commun. 2014;9(8):1211-6. PMID 25233607. Review of reported interactions between warfarin and medicinal herbs, including bleeding events with dang gui, dan shen, ginger, ginseng and Boswellia.
- Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-23. PMID 18728265. JAMA study finding detectable lead, mercury or arsenic in about one fifth of Ayurvedic medicines purchased over the Internet.
This page is for general education and is not medical advice. Acupuncture, Ayurvedic medicine and herbal medicine are complementary therapies; they do not replace diagnosis or treatment by your physician. Do not stop or change prescribed treatment without talking to your prescriber. In an emergency call 911.
























